Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
J.H. Whitney
AddedFeb 13, 2024
UpdatedJun 28, 2026
J.H. Whitney

J.H. Whitney

Operating

J.H. Whitney & Co: A US-based venture capital firm specializing in leveraged buyouts and turnarounds.

Location
New Canaan, CT, US
Founded
1946
Firm
Compare
Portfolio
Employees
Website

Investments

Grande Communications
Grande Communications
Acquired

Total Raised

$315M

Rounds

4

Series Unknown$45MOctober 2003
Series Unknown$20MNovember 2001
Private Equity$225MFebruary 2000
Eventra
Eventra

Total Raised

$32M

Rounds

2

Series C$24MJanuary 2001
Series B$8MMarch 2000
GlobalSight
GlobalSight

Total Raised

$41.9M

Rounds

3

Series C$29MDecember 2000
Series B$12.9MDecember 1999
Home Link Services
Home Link Services

Total Raised

$37.5M

Rounds

2

Series B$25MSeptember 2000
Series A$12.5MJanuary 1999
Carolina Broadband
Carolina Broadband

Total Raised

$402M

Rounds

1

Private Equity$402MMay 2000
AdvisorTech
AdvisorTech

Total Raised

$25M

Rounds

1

Private Equity$25MMay 2000
iSolve
iSolve

Total Raised

$30M

Rounds

1

Series Unknown$30MMay 2000
USA Digital Radio
USA Digital Radio

Total Raised

$41M

Rounds

1

Private Equity$41MMay 2000
DentalXChange
DentalXChange

Total Raised

$131.8M

Rounds

4

Series B$16MApril 2000
Series A$5MSeptember 1999
Medem
Medem

Total Raised

$21.7M

Rounds

2

Series Unknown$20MMarch 2000
Supportkids
Supportkids

Total Raised

$9M

Rounds

2

Series B$9MMarch 2000
Cushopper
Cushopper

Total Raised

$16.6M

Rounds

1

Series Unknown$16.6MFebruary 2000
401 Kexchange
401 Kexchange

Total Raised

$3.1M

Rounds

1

Series Unknown$3.1MFebruary 2000
Grantlun
Grantlun

Total Raised

$11M

Rounds

1

Series Unknown$11MFebruary 2000
Neoteny
Neoteny

Total Raised

$20M

Rounds

2

Series Unknown$20MJanuary 2000
Icon International
Icon International

Total Raised

$95M

Rounds

1

Series Unknown$95MDecember 1999
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Public

Total Raised

$656.2M

Rounds

7

Series Unknown$5.8MJuly 1989